Prosecution Insights
Last updated: October 25, 2026
Application No. 18/917,854

NUTRITIONAL SUPPLEMENTS

Non-Final OA §103
Filed
Oct 16, 2024
Priority
Apr 29, 2016 — SE 1630098-0 +4 more
Examiner
LEBLANC, KATHERINE DEGUIRE
Art Unit
Tech Center
Assignee
Laminaria Group AB
OA Round
1 (Non-Final)
35%
Grant Probability
At Risk
1-2
OA Rounds
1y 9m
Est. Remaining
71%
With Interview

Examiner Intelligence

Grants only 35% of cases
35%
Career Allowance Rate
214 granted / 619 resolved
-25.4% vs TC avg
Strong +36% interview lift
Without
With
+36.0%
Interview Lift
resolved cases with interview
Typical timeline
3y 10m
Avg Prosecution
41 currently pending
Career history
663
Total Applications
across all art units

Statute-Specific Performance

§101
0.8%
-39.2% vs TC avg
§103
63.8%
+23.8% vs TC avg
§102
8.9%
-31.1% vs TC avg
§112
22.4%
-17.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 619 resolved cases

Office Action

§103
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries set forth in Graham v. John Deere Co., 383 U.S. 1, 148 USPQ 459 (1966), that are applied for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claims 16-35 is/are rejected under 35 U.S.C. 103 as being unpatentable over Sexton(US 2014/0037830) in view of Catani(US 2007/0082114). Regarding claims 16-25,27-34 Sexton teaches a solid nutritional composition comprising, i)about 0.01 to 1wt% alginate(paragraph 126) ii)pectin as an emulsion stabilizer(paragraph 167) iii)About 1 to about 99% active ingredients such as amino acids(paragraph 76), complex carbohydrates such as maltodextrins(paragraph 75), and/or sugars such as fructose(paragraph 75,79), Sexton is silent on the amount of pectin present in the composition. However, teaches a Catani beverage composition to be taken with an exercise program comprising a combination of alginate and pectin in order to increase satiety(abstract, paragraph 73). Catani teaches that the fluid composition comprises about 0.3% to about 5% by weight of a combination of alginate and pectin, with a ratio of alginate to pectin being about 8:1 to about 1:8(paragraphs 49 and 50). Catani teaches that the pectin is ideally in the form of high methoxy(HM pectin)(paragraph 24) and the alginate is in the form of high guluronate acid (high G) alginate(paragraph 18). Sexton teaches forming the beverage by dissolving 0.1 to 60wt% of the solid composition in water(paragraph 98). Therefore, when adding the about 0.3 to about 5% alginate and pectin into the beverage of Sexton(assuming 60% solid material), the solid composition(before addition of water) would comprise 0.5-8%(0.3/60-5/60) alginate and pectin. Using the 8:1 to 1:8 alginate to pectin ratio, the solid composition would comprise 0.06-7.1% alginate and 0.06-7.1% pectin. It would have been obvious to include 0.06-7.1% high G alginate and 0.06-7.1% high methoxy pectin in solid composition of Sexton in order to increase satiety for the consumer. Sexton teaches that [0005]Understanding the body's ability to absorb and process carbohydrates and other nutrients for maximal performance output has been studied by many. In 2003, the International Olympic Committee on Nutrition for Athletes issued a position stating that a high carbohydrate diet in the days before competition helps enhance performance, particularly when exercise lasts longer than about 60 min and that athletes should aim to achieve carbohydrate intakes that meet the fuel requirements of their training programs and also adequately replace their carbohydrate stores during recovery between training sessions and competition. However, this is a difficult task, especially for athletes in training who need a sustained supply of carbohydrates and other nutrients without the drawback of an intake of large amounts or smaller amounts but at more regular intervals, of food in order to meet the dietary requirements necessary to maintain enhanced performance. [0006] There is thus a need in the art to provide a sustained and controlled supply of carbohydrates and other nutrients to individuals without the necessity of intake of excess food and snacks. Therefore, the satiety increasing effect of the pectin and alginate composition of Catani would help an athlete stay satiated so they do not intake too many unnecessary calories and only receive the needed carbohydrates from the sports drink. Furthermore, the satiety increasing effect of the composition of Catani would be beneficial to athletes since many athletes are either losing or maintaining weight for optimum performance. Sexton teaches that the solid composition can comprise 1 to 99% active ingredients such as sugars(paragraph 75), which would overlap the claimed amount of more than 30 wt% sugars. Sexton teaches that the solid composition can comprise 1 to 99% complex carbohydrates such as maltodextrin(paragraph 75), which would overlap the claimed amount of more than 40 wt% maltodextrin. Regarding claims 26,35, Sexton teaches that the solid composition forms a liquid composition when it dissolves in water which further gels in a low-pH environment(para 73,15). Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to KATHERINE D LEBLANC whose telephone number is (571)270-1136. The examiner can normally be reached 8AM-4PM EST M-F. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Nikki Dees can be reached at 571-270-3435. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /KATHERINE D LEBLANC/Primary Examiner, Art Unit 1791
Read full office action

Prosecution Timeline

Oct 16, 2024
Application Filed
Oct 05, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12765574
PROTEIN HYDROLYSATE DERIVED FROM BLUE-BACKED FISH
4y 8m to grant Granted Oct 20, 2026
Patent 12729247
INHIBITED POROUS GRANULAR STARCHES AND METHODS OF MAKING AND USING THEM
3y 11m to grant Granted Sep 08, 2026
Patent 12721366
MEDIUM/LOW GLYCAEMIC INDEX PRODUCTS AND METHODS
6y 1m to grant Granted Sep 01, 2026
Patent 12703843
METHOD AND SYSTEM FOR THE FILTRATION AND STABILIZATION OF ULTRA-HIGH GRAVITY ALCOHOLIC BEVERAGES
4y 10m to grant Granted Aug 11, 2026
Patent 12698396
BLUE PIGMENT AND METHOD FOR PRODUCING SAME
3y 5m to grant Granted Aug 04, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
35%
Grant Probability
71%
With Interview (+36.0%)
3y 10m (~1y 9m remaining)
Median Time to Grant
Low
PTA Risk
Based on 619 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month